| Philvie Guery Nestor, | |
|
395 Wiklund Ave, Stratford, CT 06614-4524 | |
| (203) 520-1982 | |
| Not Available |
| Full Name | Philvie Guery Nestor |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 395 Wiklund Ave, Stratford, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033394317 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 032201 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Philvie Guery Nestor, 395 Wiklund Ave, Stratford, CT 06614-4524 Ph: (203) 520-1982 | Philvie Guery Nestor, 395 Wiklund Ave, Stratford, CT 06614-4524 Ph: (203) 520-1982 |
News Archive
Neurotechnology, a provider of high-precision biometric identification technologies, has released new versions of the company's core product Software Development Kits (SDKs) for fingerprint, face, iris and multi-biometric identification. The latest SDK versions, VeriFinger 6.1, VeriLook 3.3, VeriEye 2.1 and MegaMatcher 3.0, provide enhanced interoperability, reliability and ease-of-maintenance over previous versions.
When the U.S. Food and Drug Administration declared in 2004 that certain antidepressants are linked to an increased risk of suicide in adolescents, there was surprisingly little data about how depression was being treated in young patients.
Tight junctions are multi-protein complexes that serve as barriers in epithelial tissues such as the skin or lining of the gut. Loss of a specific tight junction barrier protein, claudin 18, occurs in the majority of gastric cancer patients and is correlated with poor prognosis in patients with advanced gastric cancer.
Juventas Therapeutics, a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease, is pleased to report that it is actively enrolling patients in a placebo-controlled, randomized double-blinded Phase IIa study evaluating the safety and efficacy for JVS-100 in patients with Rutherford Class 4 or 5 critical limb ischemia.
Stimulating the brain to alter its intrinsic reward system shows promise in the treatment of obesity, according to results presented in Barcelona at the European Society of Endocrinology annual meeting, ECE 2018.
› Verified 9 days ago
Samara Dejesus, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 419 Bruce Ave, Stratford, CT 06615 Phone: 203-923-4211 | |
Guylene Buissereth, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1786 Broadbridge Ave, Stratford, CT 06614 Phone: 203-690-0388 | |
Merline Phidd, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 190 Milford Ave, Stratford, CT 06615 Phone: 203-684-6252 | |
Jermaine Richards, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3303 Main St, Stratford, CT 06614 Phone: 203-377-2220 | |
Lynette Stinvil, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 46 Booth St, Stratford, CT 06614 Phone: 203-549-7187 | |
Rudy Anthony Brown, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 67 Shirley Dr, Stratford, CT 06614 Phone: 203-610-5455 |